Non-squamous Non-small Cell Lung Cancer Clinical Trials in Toronto, Ontario
2 recruitingToronto, Ontario, Canada
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Non-squamous Non-small Cell Lung Cancer
AbbVie854 enrolled53 locationsNCT07005102
Recruiting
Phase 2
Study of Crizotinib for ROS1 and MET Activated Lung Cancer
Stage IV Non-Small Cell Lung CancerMET AmplificationNon-squamous Non-small Cell Lung Cancer+2 more
University Health Network, Toronto50 enrolled1 locationNCT04084717